Menu

Filtros : "ENDOMETRIOSE" "AbbVie Inc." Removido: "Austrália" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain (2019)

    Leyland, Nicholas; Taylor, Hugh S; Archer, David F; Peloso, Paul M; Soliman, Ahmed M; Palac, Hannah L; Martinez, Marisol; Abrao, Mauricio Simões

    Source: Journal of endometriosis and pelvic pain disorders. Unidade: FM

    Subjects: DISPAREUNIA, ENDOMETRIOSE, MENOPAUSA, CLIMATÉRIO, DOR, QUALIDADE DE VIDA, HORMÔNIO LIBERADOR DE GONADOTROFINAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LEYLAND, Nicholas et al. Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain. Journal of endometriosis and pelvic pain disorders, v. 11, n. 4, p. 171-180, 2019Tradução . . Disponível em: https://doi.org/10.1177/2284026519872401. Acesso em: 18 nov. 2024.

    • APA

      Leyland, N., Taylor, H. S., Archer, D. F., Peloso, P. M., Soliman, A. M., Palac, H. L., et al. (2019). Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain. Journal of endometriosis and pelvic pain disorders, 11( 4), 171-180. doi:10.1177/2284026519872401

    • NLM

      Leyland N, Taylor HS, Archer DF, Peloso PM, Soliman AM, Palac HL, Martinez M, Abrao MS. Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain [Internet]. Journal of endometriosis and pelvic pain disorders. 2019 ; 11( 4): 171-180.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/2284026519872401

    • Vancouver

      Leyland N, Taylor HS, Archer DF, Peloso PM, Soliman AM, Palac HL, Martinez M, Abrao MS. Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain [Internet]. Journal of endometriosis and pelvic pain disorders. 2019 ; 11( 4): 171-180.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/2284026519872401

  • Trabalho de evento-resumo periodico

    Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies (2017)

    Surrey, E.; Taylor, H. S.; Giudice, L. C; Singh, S; Abrão, Maurício Simões; Lessey, B. A; Duan, W. R; Peloso, P. M; Schwefel, B; Chwakusz, K

    Source: Fertility and sterility. Conference titles: Scientific Congress and Expo of the American-Society-for-Reproductive-Medicine (ASRM). Unidade: FM

    Subjects: ENDOMETRIOSE, HORMÔNIO LIBERADOR DE GONADOTROFINAS, ENDOMÉTRIO, TERAPÊUTICA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SURREY, E. et al. Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies. Fertility and sterility. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397c. Acesso em: 18 nov. 2024. , 2017

    • APA

      Surrey, E., Taylor, H. S., Giudice, L. C., Singh, S., Abrão, M. S., Lessey, B. A., et al. (2017). Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies. Fertility and sterility. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397c

    • NLM

      Surrey E, Taylor HS, Giudice LC, Singh S, Abrão MS, Lessey BA, Duan WR, Peloso PM, Schwefel B, Chwakusz K. Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies [Internet]. Fertility and sterility. 2017 ; 108( 3): E95-E96.[citado 2024 nov. 18 ] Available from: https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397c

    • Vancouver

      Surrey E, Taylor HS, Giudice LC, Singh S, Abrão MS, Lessey BA, Duan WR, Peloso PM, Schwefel B, Chwakusz K. Long-term safety and efficacy of elagolix treatment in women with endometriosis associated pain: primary results from two phase 3 extension studies [Internet]. Fertility and sterility. 2017 ; 108( 3): E95-E96.[citado 2024 nov. 18 ] Available from: https://ac.els-cdn.com/S0015028217308142/1-s2.0-S0015028217308142-main.pdf?_tid=befbe701-63d1-4965-8ea4-7c46f2e26dd8&acdnat=1523300337_01f35b643bd672c0351c91e49928397c
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024